China Dongxiang Group Co Ltd (3818)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 27 Oct 2026
Key indicators
| Last close | HKD 0.241 |
|---|---|
| 52-week range | 0.240 – 0.520 |
| Return, 1 month / 3 months | −10.7% / −16.9% |
| Return, 1 year / 3 years | −52.5% / +4.8% |
| Trend | Below its 200-day average |
| RSI (14) | 28 |
| Volatility (1 year) | 36.1% |
| Worst drawdown (1 year) | -54.3% |
| Average daily value traded | 0.76M HKD |
| Dividend yield | 4.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
China Dongxiang Group designs, sources and distributes sportswear and outdoor apparel, chiefly under the Kappa brand in China, where it sells through retail stores and distributors to consumers. The company also owns the Phenix brand of ski and outdoor clothing, which it markets in Japan and other markets. It is based in Hong Kong and manages product development, branding and retail distribution for its sports and leisure labels.
On this site China Dongxiang Group Co Ltd appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 3818, with prices in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
China Dongxiang Group Co Ltd (3818) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 0.241 on 27 October 2026.
Its price-based Market X-Ray is 38 out of 100 (a weak price profile), ranking 1,829 of 2,619 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 52.5% and over the last three months it fell 16.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 21 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -33.3% | ||
| From 52-week high | -53.7% | ||
| Momentum | 21 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -16.9% | ||
| 6-month return | -41.9% | ||
| 12-month return, skipping the last month | -46.8% | ||
| Stability (higher is calmer) | 59 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 36.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -54.3% | ||
| Liquidity | 60 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.76M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 36 · Weak | Dividend is small or irregular. | |
| Dividend yield | 4.7% | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −7.3% |
|---|---|
| 1 month | −10.7% |
| 3 months | −16.9% |
| 6 months | −41.9% |
| 1 year | −52.5% |
| 3 years | +4.8% |
| 5 years | −66.0% |
Signals
| 50-day / 200-day average | 0.271 / 0.361 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.008 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Dec 2025 | HKD 0.0114 |
| 26 Aug 2025 | HKD 0.0078 |
| 9 Dec 2024 | HKD 0.0076 |
| 26 Aug 2024 | HKD 0.0056 |
| 5 Dec 2023 | HKD 0.0077 |
| 21 Aug 2023 | HKD 0.0053 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.